student looking in microscope

Division of Biomedical Sciences

Breadcrumb

The Division of Biomedical Sciences at the UCR School of Medicine has a rich tradition of high-impact research on medically relevant topics, student-centered teaching excellence and a service within the academic community.



Employment Opportunities

Interested in a career in the Division of Biomedical Sciences and the UCR School of Medicine? You can find a complete listing of open positions on the employment page of the SOM website.


Biomedical Sciences News

breathing illustrated
Dusty air is rewriting your lung microbiome
Genetic or bacterial diseases have previously been shown to have an effect on lung microbes. However, a UC Riverside discovery marks the first time scientists have observed such changes from environmental exposure rather than disease. 
Read More »
demonstrating a microscope
SOM Hosts All Research Cores Symposium
Read More »
Firing neuron
New hope for MS
Scientists identify two compounds that could benefit people living with multiple sclerosis
Read More »
Demyelination of neuron
How brain myelin damage could lead to seizures in MS
Study may explain why some people living with multiple sclerosis experience epileptic seizures
Read More »
Girl has concussion
Childhood concussions may trigger long-term brain changes
Researchers call for extended care and monitoring after pediatric head injuries
Read More »
UCR SOM Participates in 2025 Rally for Medical Research
A UCR School of Medicine delegation traveled to Washington, D.C., to participate in the Rally for Medical Research on September 18, 2025. The UCR delegation was part of more than 400 researchers and experts who visited congressional offices to advocate for sustained investment in medical research. 
Read More »
CCHFV
NIH grant supports research on dangerous emerging virus
International team to study immune defenses against Crimean-Congo hemorrhagic fever virus
Read More »
Maurizio Pellecchia and Carlo Baggio
UCR startup secures grant to advance cancer therapy
NIH award of $2.25M funds preclinical studies that will advance Targefrin toward clinical trials for pancreatic cancer
Read More »